Heparin binding domain of insulin-like growth factor binding protein-5 stimulates mesangial cell migration

American Journal of Physiology - Renal Physiology

Volumn 273, Issue 6 42-6, 1997, Pages

  Abrass, Christine K ^a,b   Berfield, Anne K ^a   Andress, Dennis L ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b Veterans Affairs   (United States)

Author keywords

Chemotaxis; Glomerulus; Insulin like growth factor I; Rat

Indexed keywords

DISINTEGRIN; HEPARIN; HEPARIN BINDING PROTEIN; IODINE 125; KISTRIN; RECOMBINANT SOMATOMEDIN C; SOMATOMEDIN BINDING PROTEIN 5; SOMATOMEDIN C;

ANIMAL CELL; ARTICLE; CELL MIGRATION; CHEMOTAXIS; CONTROLLED STUDY; DOSE RESPONSE; MESANGIUM CELL; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0031427416     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.1997.273.6.f899     Document Type: Article

References (54)

1. Abrass, C. K., G. J. Raugi, L. S. Gabourel, and D. H. Lovett. Insulin and insulin-like growth factor I binding to cultured rat glomerular mesangial cells. Endocrinology 123: 2432-2439, 1988.
2. Abrass, C. K., D. Spicer, and G. J. Raugi. Insulin induces a change in extracellular matrix glycoproteins synthesized by rat mesangial cells in culture. Kidney Int. 46: 613-620, 1994.
3. Abrass, C. K., D. Spicer, and G. J. Raugi. Induction of nodular sclerosis by insulin in rat mesangial cells in vitro: studies of collagen. Kidney Int. 47: 25-37, 1995.
4. Andress, D. L. Heparin modulates the binding of insulin-like growth factor (IGF) binding protein-5 to a membrane protein in osteoblastic cells. J. Biol. Chem. 270: 28289-28303, 1995.
5. Andress, D. L., and R. S. Birnbaum. Human osteoblast-derived insulin-like growth factor (IGF) binding protein-5 stimulates osteoblast mitogenesis and potentiates IGF action. J. Biol. Chem. 267: 22467-22472, 1992.
6. Andress, D. L., S. M. Loop, J. Zapf, and M. C. Kiefer. Carboxy-truncated insulin-like growth factor binding protein-5 stimulates mitogenesis in osteoblast-like cells. Biochem. Biophys. Res. Commun. 195: 25-30, 1993.
7. Arai, T., A. Arai, W. H. Busby, Jr., C. Camacho-Hubner, and D. R. Clemmons. Glycosaminoglycans inhibit degradation of insulin-like growth factor binding protein-5. Endocrinology 135: 2358-2363, 1994.
8. Arai, T., A. Parker, W. H. Busby, Jr., and D. R. Clemmons. Heparin, heparan sulfate, and dermatan sulfate regulate formation of insulin-like growth factor-I and insulin-like growth factor-binding protein complexes. J. Biol. Chem. 269: 20388-20393, 1994.
9. Arnqvist, H. J., B. J. Ballermann, and G. L. King. Receptors for and effects of insulin and IGF-I in rat glomerular mesangial cells. Am. J. Physiol. 254 (Cell Physiol. 23): C411-C416, 1988.
10. Aron, D. C., J. L. Rosenzweig, and H. E. Abboud. Synthesis and binding of insulin-like growth factor-I by human glomerular mesangial cells. J. Clin. Endocrinol. Metab. 68: 585-591, 1989.
11. Baker, J., J. P. Liu, E. J. Robertson, and A. Efstratiadis. Role of insulin-like growth factors in embryonic and postnatal growth. Cell 75: 73-82, 1993.
12. Bar, R. S., B. A. Booth, M. Moes, and B. L. Dake. Insulin-like growth factor binding proteins from vascular endothelial cells: purification, characterization and intrinsic biological activities. Endocrinology 125: 1910-1920, 1989.
13. Bauer, J. S., C. L. Schreiner, F. G. Giancotti, E. Ruoslahti, and R. L. Juliano. Motility of fibronectin receptor-deficient cells on fibronectin and vitronectin: collaborative interactions among integrins. J. Cell Biol. 116: 477-487, 1992.
14. Ben-Ze'ev, A. Animal cell shape changes and gene expression. Bioessays 13: 207-212, 1991.
15. Berfield, A. K., D. Spicer, and C. K. Abrass. Insulin-like growth factor I (IGF-I) induces unique effects in the cytoskeleton of cultured rat glomerular mesangial cells. J. Histochem. Cytochem. 45: 583-593, 1997.
16. Booth, B. A., M. Boes, D. L. Andress, B. L. Dake, M. C. Kiefer, C. Maack, R. J. Linhardt, K. Bar, E. E. O. Caldwell, J. Weiler, and R. S. Bar. IGFBP-3 and IGFBP-5 association with endothelial cells: role of c-terminal heparin binding domain. Growth Regul. 5: 1-17, 1995.
17. 3 for angiogenesis. Science 264: 567-571, 1994.
18. Clemmons, D. R., M. L. Dehoff, W. H. Busby, M. L. Bayne, and M. A. Cascieri. Competition for binding to insulin-like growth factor (IGF) binding protein-2,3,4 and 5 by the IGFs and IGF analogs. Endocrinology 131: 890-895, 1992.
19. Conti, F., L. Striker, S. Elliot, D. Andreani, and G. E. Striker. Synthesis and release of insulinlike growth factor I by mesangial cells in culture. Am. J. Physiol. 255 (Renal Fluid Electrolyte Physiol. 24): F1214-F1219, 1988.
20. Conti, F., L. Striker, M. Lesniak, K. MacKay, J. Roth, and G. E. Striker. Studies on binding and mitogenic effect of insulin and insulin-like growth factor I (IGF I) in glomerular mesangial cells. Endocrinology 122: 2788-2795, 1988.
21. Cosio, F. G. Cell-matrix adhesion receptors: relevance to glomerular pathology. Am. J. Kidney Dis. 20: 294-305, 1992.
22. Doerr, M. E., and J. I. Jones. The roles of integrins and extracellular matrix proteins in the insulin-like growth factor I-stimulated chemotaxis of human breast cancer cells. J. Biol. Chem. 271: 2443-2447, 1996.
23. Dowrick, P. G., and R. M. Warn. The cellular response to factors which induce motility in mammalian cells. Experientia 59: 89-108, 1991.
24. Dunlevy, J. R., and J. R. Couchman. Controlled induction of focal adhesion disassembly and migration in primary fibroblasts. J. Cell Sci. 105: 489-500, 1993.
25. Feld, S. M., R. Hirschberg, A. Artishevsky, C. Nast, and S. G. Adler. Insulin-like growth factor I induces mesangial proliferation and increases mRNA and secretion of collagen. Kidney Int. 48: 45-51, 1995.
26. Flyvbjerg, A., O. Thorlacius-Ussing, R. Naeraa, J. Ingerslev, and H. Orskov. Kidney tissue somatomedin C and initial renal growth in diabetic and uninephrectomized rats. Diabetologia 31: 310-314, 1988.
27. Gockerman, A., T. Prevette, J. I. Jones, and D. R. Clemmons. Insulin-like growth factor (IGF)-binding proteins inhibit the smooth muscle cell migration responses to IGF-I and IGF-II. Endocrinology 136: 4168-4173, 1995.
28. Grellier, P., M. Sabbah, B. Fouqueray, K. Woodruff, D. Yee, H. E. Abboud, and S. L. Abboud. Characterization of insulin-like growth factor binding proteins and regulation of IGFBP3 in human mesangial cells. Kidney Int. 49: 1071-1078, 1996.
29. Hoock, T. C., P. M. Newcomb, and I. M. Herman, β actin and its mRNA are localized at the plasma membrane and the regions of moving cytoplasm during the cellular response to injury. J. Cell Biol. 112: 653-664, 1991.
30. Ingber, D. E., and J. Folkman. Mechanochemical switching between growth and differentiation during fibroblast growth factor-stimulated angiogenesis in vitro: role of extracellular matrix. J. Cell Biol. 109: 317-330, 1989.
31. Jones, J. I., and D. R. Clemmons. Insulin-like growth factors and their binding proteins: biological activity. Endocr. Rev. 16: 3-34, 1995.
32. Jones, J. I., A. Gockerman, W. H. Busby, Jr., C. Camacho-Hubner, and D. R. Clemmons. Extracellular matrix contains insulin-like growth factor binding protein 5: potentiation of the effects of IGF-I. J. Cell Biol. 121: 679-687, 1993.
33. 1 integrin by means of its Arg-Gly-Asp sequence. Proc. Natl. Acad. Sci. USA 90: 10553-10557, 1993.
34. 3 integrin is necessary for smooth muscle cells to migrate in response to insulin-like growth factor I. Proc. Natl. Acad. Sci. USA 93: 2482-2487, 1996.
35. LaFlamme, S. E., S. K. Akiyama, and K. M. Yamada. Regulation of fibronectin receptor distribution. J. Cell Biol. 117: 437-447, 1992.
36. Landau, D., E. Chin, C. Bondy, H. Domene, C. T. Roberts, Jr., H. Gronbaek, A. Flyvbjerg, and D. LeRoith. Expression of insulin-like growth factor binding proteins in the rat kidney: effects of long-term diabetes. Endocrinology 136: 1835-1842, 1995.
37. Manske, M., and E. G. Bade. Growth factor-induced cell migration: biology and methods of analysis. Int. Rev. Cytol. 155: 49-96, 1994.
38. Matsell, D. G., P. J. D. Delhanty, O. Stepaniuk, C. Goodyer, and V. K. M. Han. Expression of insulin-like growth factor and binding protein genes during nephrogenesis. Kidney Int. 46: 1031-1042, 1994.
39. Miyata, Y., E. Nishida, S. Koyasu, I. Yahara, and H. Sakai. Protein kinase C-dependent and -independent pathways in the growth factor-induced cytoskeletal reorganization. J. Biol. Chem. 264: 15565-15568, 1989.
40. Mohan, S., Y. Nakao, Y. Honda, E. Landale, U. Leser, C. Dony, K. Lang, and D. J. Baylink. Studies on the mechanisms by which insulin-like growth factor (IGF) binding protein-4 (IGFBP-4) and IGFBP-5 modulate IGF actions in bone cells. J. Biol. Chem. 270: 20424-20431, 1995.
41. Mueller, R. V., E. M. Spencer, A. Sommer, C. A. Maack, D. Suh, and T. K. Hunt. The role of IGF-1 and IGFBP-3 in wound healing. In: Modern Concepts of Insulin-Like Growth Factors, edited by E. M. Spencer. New York: Elsevier, 1991, p. 185-192.
42. Oh, Y., H. L. Muller, G. Lamson, and R. G. Rosenfeld. Insulin-like growth factor (IGF)-independent actions of IGF-binding protein-3 in Hs578T human breast cancer cells. J. Biol. Chem. 268: 14964-14971, 1993.
43. Parker, A., J. B. Clarke, W. H. Busby, Jr., and D. R. Clemmons. Identification of the extracellular matrix binding sites for insulin-like growth factor-binding protein 5. J. Biol. Chem. 271: 13523-13529, 1996.
44. Person, J. M., D. H. Lovett, and G. J. Raugi. Modulation of mesangial cell migration by extracellular matrix components. Inhibition by heparinlike glycosaminoglycans. Am. J. Pathol. 133: 609-614, 1988.
45. Petermann, A., H. Fees, H. Grenz, S. L. Goodman, and R. B. Sterzel. Polymerase chain reaction and focal contact formation indicate integrin expression in mesangial cells. Kidney Int. 44: 997-1005, 1993.
46. Price, G. J., J. L. Berka, S. R. Edmondson, G. A. Werther, and L. A. Bach. Localization of mRNAs for insulin-like growth factor binding proteins 1 to 6 in rat kidney. Kidney Int. 48: 402-411, 1995.
47. Ridley, A. J., and A. Hall. The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell 70: 389-399, 1992.
48. Sara, V. R., and K. Hall. The insulin-like growth factors and their binding proteins. Physiol. Rev. 70: 591-614, 1990.
49. Schlaepfer, D. D., S. K. Hanks, T. Hunter, and P. Van de Geer. Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase. Nature 372: 786-791, 1994.
50. Schreiber, B. D., M. L. Hughes, and G. C. Groggel. Insulin-like growth factor-1 stimulates production of mesangial cell matrix components. Clin. Nephrol. 43: 368-374, 1995.
51. 1 integrin variants in laminin adhesion by cDNA expression in an ag integrin-deficient macrophage cell line. J. Biol. Chem. 268: 11401-11408, 1993.
52. Shikata, K., H. Makino, S. Morioka, T. Kashitani, K. Hirata, Z. Ota, J. Wada, and Y. S. Kanwar. Distribution of extracellular matrix receptors in various forms of glomerulonephritis. Am. J. Kidney Dis. 25: 680-688, 1995.
53. Stossel, T. P. On the crawling of animal cells. Science 260: 1086-1094, 1993.
54. Warn, W., D. Brown, P. Dowrick, A. Prescott, and A. Warn. Cytoskeletal changes associated with cell motility. Symp. Soc. Exp. Biol. 47: 325-338, 1993.